The lymphocyte–monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy

BACKGROUND: The lymphocyte–monocyte ratio (LMR), a simple biomarker that can reflect the antitumor immune response of the host, has been associated with patient prognosis in several solid tumors. The aim of this study was to evaluate whether LMR can predict clinical tumor response and prognosis in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xuemei, Li, Minghuan, Zhao, Fen, Zhu, Yingming, Luo, Yijun, Kong, Li, Zhu, Hui, Zhang, Yan, Shi, Fang, Yu, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317323/
https://www.ncbi.nlm.nih.gov/pubmed/28243122
http://dx.doi.org/10.2147/OTT.S124915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317323/
https://www.ncbi.nlm.nih.gov/pubmed/28243122
http://dx.doi.org/10.2147/OTT.S124915

Ejemplares similares